Simina Ticau
Alnylam Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Amyloidosis: Diagnosis, Treatment, Outcomes, DNA Repair Mechanisms, Skin and Cellular Biology Research, Tuberculosis Research and Epidemiology, Coagulation, Bradykinin, Polyphosphates, and Angioedema
Most-Cited Works
- → Single-Molecule Studies of Origin Licensing Reveal Mechanisms Ensuring Bidirectional Helicase Loading(2015)206 cited
- → Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis(2020)98 cited
- → The Dynamics of Eukaryotic Replication Initiation: Origin Specificity, Licensing, and Firing at the Single-Molecule Level(2015)86 cited
- → Mechanism and timing of Mcm2–7 ring closure during DNA replication origin licensing(2017)86 cited
- → Viral E3 Ubiquitin Ligase-Mediated Degradation of a Cellular E3: Viral Mimicry of a Cellular Phosphorylation Mark Targets the RNF8 FHA Domain(2012)81 cited
- → Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria(2020)61 cited
- → Widespread haploid-biased gene expression enables sperm-level natural selection(2021)51 cited
- → Rare loss of function variants in the hepatokine gene INHBE protect from abdominal obesity(2022)51 cited
- → Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry(2021)29 cited
- → Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study(2023)23 cited